US Broker Ratings

MannKind Corporation (MNKD) Stock Analysis: Evaluating a Potential 154.97% Upside

MannKind Corporation (NASDAQ: MNKD) stands out in the healthcare sector as a biotechnology company with a targeted focus on endocrine and orphan lung diseases. With a..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 42.59% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) offers investors a unique opportunity within the healthcare sector, specifically in the health information services industry. With a market capitalization of..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 130% Potential Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a promising player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 130.76%. This precision medicine..

Zai Lab Limited (ZLAB): An Investor’s Insight into Potential 36% Upside in Biotech Innovation

In the dynamic world of biotechnology, Zai Lab Limited (NASDAQ: ZLAB) emerges as a compelling player with a promising portfolio and significant market presence. Based in..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 30% Potential Upside Amidst Healthcare Innovation

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a pivotal player in the healthcare sector, specializes in medical devices catering to neurosurgery, neurocritical care, and wound treatment. With..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 128.86% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors in the healthcare sector, particularly within the specialized niche of vaccine development. With its focus..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unlocking a 17.98% Upside in the Healthcare Sector

Investors looking to capitalize on the robust growth within the healthcare sector should consider The Pennant Group, Inc. (NASDAQ: PNTG). This burgeoning company, with a market..

Phreesia, Inc. (PHR) Investor Outlook: A 21.94% Upside Potential in Healthcare SaaS

Phreesia, Inc. (PHR) stands at the forefront of the Health Information Services industry, delivering a robust Software-as-a-Service (SaaS) platform that significantly enhances patient engagement and streamlines..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 75% Potential Upside in the Medical Device Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of over 75%. With a market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 13.89% Potential Upside Amid Valuation Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, commands a market capitalization of $3.17..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Unpacking a 44.88% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is making waves in the healthcare sector with a compelling potential upside of 44.88%, according to current analyst ratings. For investors..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a Potential 33.76% Upside

For investors seeking opportunities in the healthcare sector, Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) presents a compelling narrative. With a robust pipeline of innovative therapies targeting unmet..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: Exploring a 38.40% Upside Potential

Guardian Pharmacy Services, Inc. (NYSE: GRDN), a leading player in the healthcare sector, is carving a niche in the medical care facilities industry with its innovative..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 25.67% Potential Upside with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the U.S. healthcare plans industry, is gaining traction among investors, buoyed by a promising 25.67% potential upside..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 262.82% Potential Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN) has been making waves in the biotechnology sector, attracting significant attention from investors due to its promising pipeline and substantial upside potential...

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 88.94% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the competitive biotechnology sector, offering a fascinating proposition for investors with its potential 88.94% upside. As a commercial-stage..

89bio, Inc. (ETNB) Investor Outlook: Exploring a Potential 193% Upside with Innovative Biotech Solutions

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with a remarkable potential upside of 193.08%, according to analysts’ average target price of $29.45. As..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a 161% Potential Upside in the Biotech Space

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is drawing the attention of investors with its substantial growth potential in the biotechnology sector. Specializing in treatments for rare diseases,..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 152% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA) has garnered significant attention in the healthcare sector, particularly for its robust footprint within the biotechnology industry. With a market capitalization of..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook with a Promising 24.71% Potential Upside

Investors eyeing the healthcare sector should take a closer look at Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the drug manufacturing industry, specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds